Indivior (LON:INDV) Share Price Passes Above 50 Day Moving Average - Here's What Happened

Key Points

• Indivior PLC's stock recently crossed above its 50-day moving average, reaching a high of GBX 1,264 ($16.76) before closing at GBX 1,238 ($16.41).
• The company has a market capitalization of £1.93 billion and a notable debt-to-equity ratio of -170.06, indicating significant leverage.
• Insider Juliet Thompson purchased 1,925 shares at an average cost of GBX 1,388 ($18.40), reflecting confidence in the company's future prospects.

Indivior PLC (LON:INDV - Get Free Report)'s share price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 1,061.72 ($14.10) and traded as high as GBX 1,264 ($16.78). Indivior shares last traded at GBX 1,238 ($16.44), with a volume of 8,457,898 shares.

Indivior Stock Performance

The business has a 50-day moving average of GBX 1,077.72 and a two-hundred day moving average of GBX 893.93. The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52. The company has a market cap of £1.93 billion, a P/E ratio of -1,026.48, a P/E/G ratio of -5.57 and a beta of 0.19.

Insider Transactions at Indivior

In other news, insider Juliet Thompson bought 3,850 shares of the firm's stock in a transaction that occurred on Wednesday, June 11th. The stock was purchased at an average cost of GBX 1,388 ($18.43) per share, for a total transaction of £53,438 ($70,957.38). 3.44% of the stock is owned by corporate insiders.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.